Credit Suisse’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,936,000
| Closed | -$225M | – | 4065 |
|
|
2021
Q4 | $225M | Sell |
2,936,000
-4,900
| -0.2% | -$390K | 0.12% | 157 |
|
|
2021
Q3 | $221M | Buy |
2,940,900
+1,825,200
| +164% | +$139M | 0.12% | 152 |
|
|
2021
Q2 | $86.1M | Sell |
1,115,700
-696,397
| -38% | -$51.8M | 0.05% | 443 |
|
|
2021
Q1 | $133M | Sell |
1,812,097
-261,057
| -13% | -$19.3M | 0.07% | 311 |
|
|
2020
Q4 | $162M | Sell |
2,073,154
-400,336
| -16% | -$30.6M | 0.08% | 268 |
|
|
2020
Q3 | $196M | Buy |
2,473,490
+1,511,426
| +157% | +$118M | 0.12% | 173 |
|
|
2020
Q2 | $71M | Sell |
962,064
-420,772
| -30% | -$31.7M | 0.05% | 393 |
|
|
2020
Q1 | $102M | Sell |
1,382,836
-742,613
| -35% | -$58.4M | 0.09% | 218 |
|
|
2019
Q4 | $184M | Sell |
2,125,449
-9,222
| -0.4% | -$757K | 0.13% | 141 |
|
|
2019
Q3 | $171M | Buy |
2,134,671
+407,148
| +24% | +$32.6M | 0.14% | 127 |
|
|
2019
Q2 | $138M | Buy |
1,727,523
+225,320
| +15% | +$17.3M | 0.12% | 147 |
|
|
2019
Q1 | $119M | Buy |
1,502,203
+722,177
| +93% | +$54M | 0.11% | 173 |
|
|
2018
Q4 | $56.9M | Sell |
780,026
-587,509
| -43% | -$41.5M | 0.06% | 334 |
|
|
2018
Q3 | $92.6M | Sell |
1,367,535
-89,080
| -6% | -$5.68M | 0.08% | 238 |
|
|
2018
Q2 | $84.4M | Sell |
1,456,615
-125,865
| -8% | -$7.1M | 0.08% | 226 |
|
|
2018
Q1 | $82.3M | Buy |
1,582,480
+1,310,000
| +481% | +$70.8M | 0.08% | 267 |
|
|
2017
Q4 | $14.6M | Buy |
272,480
+10,480
| +4% | +$581K | 0.01% | 1042 |
|
|
2017
Q3 | $16M | Buy |
262,000
+57,640
| +28% | +$3.49M | 0.02% | 967 |
|
|
2017
Q2 | $12.5M | Sell |
204,360
-188,640
| -48% | -$11.5M | 0.01% | 1063 |
|
|
2017
Q1 | $23.8M | Sell |
393,000
-33,012
| -8% | -$2M | 0.02% | 736 |
|
|
2016
Q4 | $23.9M | Sell |
426,012
-282,960
| -40% | -$16.6M | 0.02% | 713 |
|
|
2016
Q3 | $42.2M | Buy |
708,972
+583,212
| +464% | +$34.1M | 0.04% | 499 |
|
|
2016
Q2 | $6.91M | Buy |
+125,760
| New | +$6.69M | 0.01% | 1411 |
|
|
2016
Q1 | – | Sell |
-113,918
| Closed | -$5.74M | – | 4182 |
|
|
2015
Q4 | $5.74M | Buy |
+113,918
| New | +$5.74M | 0.01% | 1481 |
|
|
2015
Q3 | – | Sell |
-29,868
| Closed | -$1.62M | – | 4396 |
|
|
2015
Q2 | $1.62M | Buy |
+29,868
| New | +$1.68M | ﹤0.01% | 2725 |
|
|
2013
Q4 | – | Sell |
-149,969
| Closed | -$6.81M | – | 4662 |
|
|
2013
Q3 | $6.81M | Buy |
149,969
+18,131
| +14% | +$828K | 0.01% | 1393 |
|
|
2013
Q2 | $5.84M | Buy |
+131,838
| New | +$5.89M | 0.01% | 1454 |
|
Other funds holding MRK
Credit Suisse's MRK Position: Q1 2024 in Review
Credit Suisse reduced its Merck (MRK) stake by 3.5% in Q1 2024, selling an estimated $28.1M and leaving 6,287,644 shares worth $830M. The position accounts for 0.79% of the portfolio, ranked #18.
Credit Suisse first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. The position peaked at $853M in Q4 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Credit Suisse held 6,287,644 shares of Merck worth $830M as of Q1 2024.
- Credit Suisse sold 227,868 Merck shares in Q1 2024, an estimated $28.1M.
- Merck made up 0.79% of Credit Suisse's portfolio in Q1 2024, its #18 holding.
- Credit Suisse first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- Credit Suisse's Merck position peaked at $853M in Q4 2022.
- 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.